| Literature DB >> 30258540 |
Cristina Sayago1, Isabel C Gonzalez Valcarcel2, Yuewei Qian2, John Lee2, Jorge Alsina-Fernandez2, Nathan C Fite2, Juan J Carrillo3, Feiyu F Zhang3, Michael J Chalmers2, Jeffrey A Dodge2, Howard Broughton1, Alfonso Espada1.
Abstract
Molecular characterization of the binding epitope of IL-23R and its cognate cytokine IL-23 is paramount to understand the role in autoimmune diseases and to support the discovery of new inhibitors of this protein-protein interaction. Our results revealed that HDX-MS was able to identify the binding epitope of IL-23R:IL-23, which opened the way to evaluate a peptide macrocycle described in the literature as disrupter of this autoimmune target. Thus, the characterization of the interactions of this chemotype by HDX-MS in combination with computational approaches was achieved. To our knowledge, this is the first reported structural evidence regarding the site where a small compound binds to IL-23R.Entities:
Year: 2018 PMID: 30258540 PMCID: PMC6142055 DOI: 10.1021/acsmedchemlett.8b00255
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345